Rep. Maloney: Oversight Committee Held Hearing With AbbVie CEO and Experts on Pricing Practices for Humira and Imbruvica
May 19, 2021
May 19, 2021
WASHINGTON, May 19 -- Rep. Carolyn Maloney, D-New York, chair of the House Oversight and Reform Committee, issued the following news release on May 18, 2021:
Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, held a full committee hybrid hearing examining the pricing and business practices of AbbVie Inc. Just before the hearing, Chairwoman Maloney released a staff report with new documents and details about AbbVie Inc., which sells the anti-infl . . .
Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, held a full committee hybrid hearing examining the pricing and business practices of AbbVie Inc. Just before the hearing, Chairwoman Maloney released a staff report with new documents and details about AbbVie Inc., which sells the anti-infl . . .